Overall, this study highlights a distinct role of YTHDF1 in promoting PC differentiation through the direct regulation of IRF4 in an m6A-dependent manner and identifies YTHDF1 as a potential target for the treatment of SLE. Here, IRF4 is linked to systemic lupus erythematosus.